human
bocaviru
hbov
parvoviru
distantli
relat
parvoviru
hbov
first
detect
nasopharyng
aspir
patient
acut
respiratori
infect
ari
recent
also
identifi
blood
fecal
sampl
patient
gastroenter
howev
role
hbov
human
infecti
diseas
unclear
due
frequent
detect
viru
associ
respiratori
virus
rv
recogn
pathogen
role
ari
inde
like
member
famili
eg
parvoviru
hbov
shed
asymptomat
prolong
period
studi
suggest
determin
hbov
load
respiratori
specimen
could
use
clarifi
role
hbov
acut
respiratori
infect
ari
studi
investig
role
hbov
ari
context
hospitalis
patient
studi
includ
control
group
asymptomat
individu
fri
et
al
show
hbov
frequent
detect
outpati
influenzalik
ill
hospitalis
patient
asymptomat
subject
laboratori
region
laboratori
andalusia
belong
nation
laboratori
network
spain
influenza
surveil
thu
influenza
season
receiv
nasalthroat
swab
outpati
symptom
ari
collect
sentinel
physician
influenza
surveil
network
laboratori
belong
refer
hospit
attend
popul
individu
respiratori
specimen
individu
ari
hospitalis
attend
emerg
unit
also
process
laboratori
investig
respiratori
virus
rv
aim
work
investig
impact
hbov
respiratori
infect
patient
attend
hospit
outpati
attend
health
care
center
studi
period
comprehend
octob
septemb
respiratori
specimen
hospitalis
patient
attend
emerg
unit
hp
ari
sent
laboratori
within
h
collect
nasalthroat
swab
outpati
op
collect
viral
transport
medium
supplement
bovin
serum
albumin
within
two
influenza
season
octob
may
sampl
sent
laboratori
within
h
routin
virolog
investig
respiratori
specimen
hp
includ
antigen
detect
techniqu
respiratori
syncyti
viru
rsv
influenza
virus
flu
simultan
cultur
mdck
cell
line
use
shellvial
assay
sv
rsv
flu
parainfluenza
viru
piv
adenoviru
adv
detect
tradit
tube
cultur
tc
rhinoviru
enteroviru
detect
specimen
op
sv
mdck
follow
rtpcr
cell
cultur
supernat
detect
type
flu
carri
hbov
human
metapneumoviru
hmpv
human
coronavirus
hcov
retrospect
investig
sampl
previous
frozen
nucleic
acid
extract
carri
sampl
use
coba
ampliprep
total
nucleic
acid
isol
kit
instrument
coba
ampliprep
roch
diagnost
mannheim
germani
realtim
pcr
hbov
detect
carri
lightcycl
faststart
dna
masterplu
hybrid
probe
kit
roch
diagnost
primer
probe
target
hbov
gene
amplif
perform
lightcycl
instrument
roch
diagnost
min
cycl
singl
fluoresc
read
taken
cycl
readout
perform
channel
hmpv
hcov
detect
cdna
synthes
nucleic
acid
use
iscripttm
revers
transcriptas
system
biorad
laboratori
hercul
ca
realtim
pcr
hmpv
carri
use
primer
probe
target
fragment
hmpv
n
gene
realtim
pcr
hcov
detect
use
primer
probe
describ
kuyper
et
al
condit
describ
hbov
realtim
pcr
use
subsequ
differenti
convent
pcr
assay
primer
probe
synthes
appli
biosystem
foster
citi
ca
usa
data
analyz
use
spss
softwar
spss
inc
chicago
il
demograph
clinic
data
collect
patient
age
sex
symptom
ari
clinic
criteria
influenzalik
ill
accord
definit
op
presenc
lower
respiratori
tract
diseas
lrtd
pneumonia
bronchiol
bronchiti
acut
exacerb
asthma
hp
hbovposit
result
along
descript
analysi
bivari
analysi
carri
compar
clinic
epidemiolog
data
virolog
result
use
chisquar
test
p
consid
signific
total
specimen
analyz
nasopharyng
aspir
nasalthroat
swab
sputum
sampl
bronchoalveolar
lavag
sex
patient
male
femal
patient
age
avail
individu
rang
year
old
median
age
year
rv
detect
specimen
flu
flu
flu
b
hbov
hmpv
rsv
adv
piv
rhinoviru
enteroviru
detect
sampl
hp
respect
hcov
investig
specimen
case
posit
distribut
frequent
detect
virus
origin
age
group
year
period
shown
tabl
comparison
hbov
detect
rate
origin
yield
signific
differ
hp
op
wherea
hmpv
detect
frequent
hp
flu
detect
rate
significantli
higher
op
result
bias
flu
virus
annual
detect
within
context
influenza
surveil
network
inde
hbov
detect
rate
statist
differ
compar
age
group
wherea
rsv
hmpv
detect
mainli
paediatr
popul
codetect
observ
subject
posit
hmpvposit
case
rsvposit
case
fluposit
case
hbov
viru
codetect
case
case
case
respect
codetect
hbov
adv
hbov
hcov
hbov
flu
hcov
hbov
hbov
rsv
hcov
hbov
hmpv
hcov
rsv
hcov
flu
hmpv
rsv
hmpv
rsv
adv
flu
adv
sinc
control
group
includ
evalu
role
hbov
ari
detect
rate
hbov
compar
two
popul
group
firstli
exclud
presenc
hbov
divid
studi
popul
two
group
one
group
comprehend
case
posit
nonhbov
virus
n
group
includ
case
neg
nonhov
virus
n
subsequ
hbov
detect
rate
calcul
group
hbov
detect
case
case
posit
neg
nonhbov
virus
respect
p
similarli
three
differ
analys
carri
frequent
detect
virus
ie
rsv
hmpv
flu
presenc
rsv
hmpv
flu
independ
compar
two
popul
group
analysi
case
posit
nonrsv
neg
nonrsv
virus
case
posit
nonhmpv
neg
nonhmpv
virus
case
posit
nonflu
virus
neg
nonflu
virus
respect
contrarili
result
obtain
hbov
signific
differ
group
observ
analysi
rsv
detect
case
posit
neg
nonrsv
virus
respect
p
hmpv
detect
case
posit
neg
nonhmpv
virus
respect
p
flu
detect
case
posit
neg
nonflu
virus
respect
p
relationship
found
hbov
detect
clinic
symptom
op
tabl
otherwis
fever
cough
ili
criteria
statist
higher
confirm
flu
case
cross
point
cp
valu
realtim
pcr
use
approxim
measur
hbov
load
previou
valid
assay
carri
intraassay
variabl
calcul
test
ten
time
two
differ
hbovposit
specimen
interassay
reproduc
calcul
test
ten
time
two
specimen
independ
run
intraassay
coeffici
variat
cp
cp
specimen
interassay
coeffici
variat
cp
cp
two
sampl
test
took
cutoff
cp
divid
hbovposit
popul
cp
highhbovload
case
cp
lowhbovload
case
significantli
higher
percentag
children
year
gave
hbov
cp
nasopharyng
swab
sampl
type
cp
compar
nasopharyng
aspir
sampl
op
gave
cp
compar
hp
cp
lrtd
report
hbovposit
hp
hbov
detect
alon
case
signific
differ
observ
cp
valu
specimen
hbov
detect
alon
codetect
compar
year
period
presenc
lrtd
tabl
clinic
symptom
op
associ
upper
respiratori
tract
infect
correl
higher
hbov
load
rsv
frequent
detect
viru
hospitalis
children
viru
main
caus
agent
bronchiol
higher
detect
rate
flu
op
probabl
due
differ
method
use
popul
group
rtpcr
sv
supernat
previous
demonstr
sensit
detect
flu
classic
rv
piv
adv
rhinoviru
may
diagnos
sv
method
use
routin
investig
virus
includ
antigen
detect
andor
viral
cultur
sv
detect
rate
rv
hp
lower
report
studi
methodolog
may
contribut
differ
mani
virologist
current
use
molecular
assay
rv
detect
sensit
cell
cultur
inde
molecular
assay
allow
detect
newlyidentifi
rv
grow
grow
poorli
cell
cultur
welldefin
etiolog
role
respiratori
tract
infect
occur
hmpv
method
led
frequent
codetect
reason
pcr
method
diagnosi
ari
may
sometim
provid
limit
valu
inform
virologist
give
clinician
occur
rv
hbov
might
asymptomat
shed
respiratori
tract
prolong
time
thu
hbovposit
result
probabl
give
inform
detect
virus
rsv
hmpv
flu
term
clinic
signific
result
demonstr
hbov
detect
independ
presenc
respiratori
viru
sinc
detect
rate
hbov
observ
case
without
viru
contrarili
respiratori
virus
hmpv
rsv
flu
recogn
causal
agent
ari
detect
frequent
alon
viru
previou
studi
compar
presenc
hbov
patient
ari
control
group
one
studi
high
hbov
detect
rate
detect
children
year
though
signific
differ
observ
symptomat
asymptomat
patient
anoth
studi
hbov
detect
children
pneumonia
clinic
find
associ
probabl
codetect
virus
final
kesebir
et
al
detect
hbov
patient
ari
neg
rsv
flu
piv
adv
compar
asymptomat
individu
howev
hbov
investig
pcr
virus
direct
fluoresc
assay
thu
virus
could
underdiagnos
less
sensit
detect
method
employ
author
could
demonstr
clear
associ
hbov
detect
symptom
ili
op
contrast
flu
significantli
associ
fever
cough
ili
previous
report
tabl
inde
signific
differ
found
hbov
detect
rate
op
hp
although
previou
studi
report
hbov
case
hp
pneumonia
semiquantit
analysi
hbov
load
carri
evalu
higher
load
could
correl
clinic
signific
presenc
hbov
respiratori
sampl
author
previous
report
establish
cutoff
cp
valu
approxim
correspond
copiesreact
although
made
modif
method
sinc
demonstr
good
reproduc
assum
cutoff
establish
clearli
differenti
patient
higher
lower
hbov
load
signific
differ
observ
cp
valu
specimen
hbov
detect
alon
codetect
significantli
higher
percentag
children
year
gave
hbov
cp
tabl
result
surpris
sinc
children
higher
titer
rv
fact
certain
rapid
tool
diagnosi
rv
antigen
detect
method
use
children
wherea
use
adult
popul
especi
immunocompromis
patient
recommend
thu
higher
hbov
load
respiratori
specimen
interpret
care
children
nasalthroat
swab
gave
cp
compar
nasopharyng
aspir
inde
sampl
op
gave
cp
compar
hp
cp
nasalthroat
swab
specimen
taken
op
nasopharyng
aspir
hp
rule
higher
viral
load
latter
due
better
sampl
instead
real
pathogen
role
hbov
previou
report
assess
recoveri
rate
respiratori
virus
nasopharyng
aspir
better
nasal
andor
throat
swab
final
hbov
compar
clinic
symptom
ili
op
hbov
load
presenc
absenc
lrtd
hbovposit
hp
clinic
symptom
op
associ
upper
respiratori
tract
infect
correl
presenc
hbov
lrtd
report
hbovposit
hp
hbov
detect
alon
case
howev
higher
hbov
load
associ
presenc
lrtd
tabl
thu
hbov
dna
frequent
detect
respiratori
specimen
could
demonstr
presenc
hbov
andor
higher
load
correl
clinic
symptom
ili
lrtd
whether
hbov
must
routin
investig
patient
ari
defin
result
obtain
analysi
could
limit
certain
case
sever
diseas
andor
absenc
respiratori
pathogen
might
justifi
hbov
investig
